Abstract
Background
L-arginine and sodium butyrate may improve glycemic control and reduce appetite by increasing glucagon-like peptide-1 (GLP-1) secretion. This warrants further investigation in individuals with obesity.
Aims
This study aimed to examine the effects of oral L-arginine, alone and with sodium butyrate, on circulating levels of GLP-1 and glucose, and subsequent appetite, in adults with obesity.
Methods
Seven adults (5 females and 2 males) with obesity participated in the study. Each participant underwent three different interventions at 2-week intervals following consumption of a standard meal (Ensure® 250 mL): 1) no intervention, 2) oral L-arginine administered 60 min before the meal, and 3) a combination of oral L-arginine and sodium butyrate administered 60 min before the meal. Blood samples for GLP-1 and glucose were collected, and hunger and fullness were assessed using visual analog scales over a 165-min period. Statistical analysis was performed using Friedman test for repeated measures. Wilcoxon signed-rank tests with Bonferroni correction were used for pairwise comparisons.
Results
Oral L-arginine combined with sodium butyrate significantly increased the area under the curve of plasma GLP-1 (AUCGLP−1) compared to no intervention (p = 0.0156). L-arginine alone showed a trend towards increased AUCGLP−1 compared to no intervention (p = 0.031). No significant differences in glucose levels were observed between interventions. Neither intervention affected subjective satiety measures.
Conclusion
Oral L-arginine and sodium butyrate increased circulating GLP-1 levels in adults with obesity. L-arginine alone showed a similar trend.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
